World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
18321
World Ranking
16829
National Ranking
884

Benedikt Schoser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Benedikt Schoser sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 588 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Benedikt Schoser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Benedikt Schoser sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Benedikt Schoser is affiliated with Ludwig-Maximilians-Universität München in Germany. Their work primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in subfields such as Physiology, Molecular Biology, Neurology, Rheumatology, and Cellular and Molecular Neuroscience.

The research topics covered by Schoser include:

  • Lysosomal Storage Disorders Research
  • Glycogen Storage Diseases and Myoclonus
  • Genetic Neurodegenerative Diseases
  • Child Nutrition and Feeding Issues
  • Muscle Physiology and Disorders
  • Mitochondrial Function and Pathology
  • Neurogenetic and Muscular Disorders Research

Schoser has co-authored frequently with several researchers, including:

  • Jordi Díaz-Manera
  • Priya S. Kishnani
  • António Toscano
  • Tahseen Mozaffar
  • Mazen M. Dimachkie

The scientist has published extensively in venues focused on neuromuscular and neurological disorders. Prominent publication venues include:

  • Neuromuscular Disorders
  • Molecular Genetics and Metabolism
  • Journal of Neurology
  • Neurology
  • Journal of Neuromuscular Diseases

Among recent scholarly papers, notable works by or involving Schoser include:

  • Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial, 2021, The Lancet Neurology
  • Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial, 2021, The Lancet Neurology
  • "Neurological manifestations of COVID-19" - guideline of the German society of neurology, 2020, Neurological Research and Practice
  • Guideline for the management of myasthenic syndromes, 2023, Therapeutic Advances in Neurological Disorders
  • New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy, 2020, Brain

Best Publications

  • Non-ATG–initiated translation directed by microsatellite expansions

    Tao Zu;Brian Gibbens;Noelle S. Doty;Mário Gomes-Pereira

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

    Alexandra Pevzner;Benedikt Schoser;Katja Peters;Nicoleta-Carmen Cosma

  • The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene

    Klaus Gempel;Haluk Topaloglu;Beril Talim;Peter Schneiderat

  • Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy

    Charlotte Fugier;Arnaud F Klein;Caroline Hammer;Stéphane Vassilopoulos

  • Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy

    Francesco Saverio Tedesco;Francesco Saverio Tedesco;Mattia F. M. Gerli;Laura Perani;Sara Benedetti

  • Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.

    S. Strothotte;N. Strigl-Pill;B. Grunert;C. Kornblum

  • Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients.

    Wolfgang Müller-Felber;Rita Horvath;Klaus Gempel;Teodor Podskarbi

  • Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease

    Regina C. Betz;Benedikt G. H. Schoser;Dagmar Kasper;Kenneth Ricker

  • Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis

    Benedikt Schoser;Andrew Stewart;Steve Kanters;Alaa Hamed

  • Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review

    Antonio Toscano;Benedikt Schoser

  • Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.

    Jan Senderek;Jan Senderek;Juliane S. Müller;Marina Dusl;Tim M. Strom

  • Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.

    Maggie C. Walter;Stephan Wenninger;Simone Thiele;Julia Stauber

  • Anti-agrin autoantibodies in myasthenia gravis

    Christiane Gasperi;Arthur Melms;Benedikt Schoser;Yina Zhang

  • Pathological consequences of VCP mutations on human striated muscle

    Christian U. Hübbers;Christoph S. Clemen;Kristina Kesper;Annett Böddrich

  • Myofibrillar myopathies: a clinical and myopathological guide.

    Rolf Schröder;Benedikt Schoser

  • Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1

    Johanna Nilsson;Benedikt Schoser;Pascal Laforet;Ognian Kalev

  • Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle

    Nikolai Klymiuk;Andreas Blutke;Alexander Graf;Sabine Krause

  • An X-Linked Myopathy with Postural Muscle Atrophy and Generalized Hypertrophy, Termed XMPMA, Is Caused by Mutations in FHL1

    Christian Windpassinger;Christian Windpassinger;Benedikt Schoser;Volker Straub;Sonja Hochmeister

  • 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy

    Caroline Regnery;Cornelia Kornblum;Frank Hanisch;Stefan Vielhaber

Frequent Co-Authors

Hanns Lochmüller
Hanns Lochmüller University of Freiburg
Volker Straub
Volker Straub Newcastle University
Priya S. Kishnani
Priya S. Kishnani Duke University
Rita Horvath
Rita Horvath University of Cambridge
Barry J. Byrne
Barry J. Byrne University of Florida
Richard J. Barohn
Richard J. Barohn University of Missouri
Thomas Klopstock
Thomas Klopstock Ludwig-Maximilians-Universität München
Alan Pestronk
Alan Pestronk Washington University in St. Louis
Darren G. Monckton
Darren G. Monckton University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options beyond a traditional medical degree can be a valuable strategy for those interested in healthcare. Many accredited online programs now offer flexible pathways to rewarding roles within the field.

Nursing is one of the most popular alternate routes. If you already hold an associate’s degree in nursing, consider the adn to fnp bridge programs to fast-track your way to becoming a Family Nurse Practitioner. Similarly, for RNs seeking more autonomy, learning does rn to bsn require clinicals can clarify your next educational steps.

If you are interested in nutrition, there are excellent online degrees in nutrition that can prepare you for roles in dietetics, wellness coaching, and clinical nutrition.

For a career in healthcare leadership, it’s vital to know how to evaluate healthcare administration degree programs and select one with strong accreditation and program outcomes.

Each of these online education paths can lead to impactful careers in health and medicine, often with greater flexibility and diverse opportunities.

Best Scientists Citing Benedikt Schoser

Trending Scientists